易天股份(300812.SZ)將於1月9日起上市交易
格隆匯1月7日丨易天股份(300812.SZ)發佈首次公開發行股票並在創業板上市上市公告書,首次公開發行的1938萬股,發行價為21.46元/股,將於2020年1月9日起上市交易。
基於已實現的經營情況,發行人預計2019年全年實現營業收入4.94億元至5.26億元,同比增長14.48%至21.89%;預計歸屬於母公司股東的淨利潤為9200萬元至10100萬元,同比增長25.46%至37.73%;預計扣除非經常性損益後歸屬於母公司股東的淨利潤為8700萬元至9600萬元,同比增長20.25%至32.69%。(前述數據並非公司所作的盈利預測)
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.